Pregnancy outcome in Refsum disease: Affected fetuses and children born to an affected mother
Open Access
- 14 March 2019
- journal article
- Published by Wiley in JIMD Reports
- Vol. 46 (1) , 11-15
Abstract
We describe the case of a young woman, from a consanguineous family, affected by adult Refsum disease (ARD, OMIM#266500). ARD is a rare peroxisomal autosomal recessive disease due to deficient alpha‐oxidation of phytanic acid (PA), a branched‐chain fatty acid. The accumulation of PA in organs is thought to be responsible for disease symptoms. The patient presented only bilateral shortening of metatarsals and has been treated with a low‐PA diet. She is homoallelic for the c.135‐2A > G mutation of PHYH, and she married her first cousin carrying the same mutation. She was pregnant seven times and had two homozygous girls. Due to a potential exacerbation of the disease during the third trimester of pregnancy, her weight and plasma PA levels were monitored. No specific events were noticed for the mother during the pregnancies and postpartum periods. This case also raised the question of potential exposure to PA (and its subsequent toxicity) of a homozygous fetus in a homozygous mother. Despite modestly elevated plasma concentrations of PA at birth (<30 μmol/L), the two affected girls did not present any specific sign of ARD and have so far developed normally. As only a few determinations of plasma PA levels in the mother could be performed during pregnancies, showing mild elevations (<350 μmol/L), it remains difficult to conclude as to a possible transplacental crossing of PA.Keywords
This publication has 21 references indexed in Scilit:
- The effectiveness of long-term dietary therapy in the treatment of adult Refsum diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Phytanic acid—an overlooked bioactive fatty acid in dairy fat?Annals of the New York Academy of Sciences, 2010
- Ataxia with loss of Purkinje cells in a mouse model for Refsum diseaseProceedings of the National Academy of Sciences, 2008
- Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum diseaseJournal of Lipid Research, 2003
- Identification of PEX7 as the Second Gene Involved in Refsum DiseaseThe American Journal of Human Genetics, 2003
- Phytanoyl–Coenzyme a Hydroxylase Deficiency — The Enzyme Defect in Refsum's DiseaseNew England Journal of Medicine, 1997
- Phytanic Acid is a Retinoid X Receptor LigandEuropean Journal of Biochemistry, 1996
- A pathway for oxidative degradation of phytanic acid in mammalsBiochemical and Biophysical Research Communications, 1966
- Über das Vorkommen der 3.7.11.15-Tetramethyl-hexadecansäure (Phytansäure) in den Cholesterinestern und anderen Lipoidfraktionen der Organe bei einem Krankheitsfall unbekannter Genese (Verdacht auf Heredopathia atactica polyneuritiformis [Refsum-Syndrom])Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1963
- Heredopathia atactica polyneuritiformisin childrenThe Journal of Pediatrics, 1949